Title: Pharmacodynamics of ceftaroline against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.
Journal: Antimicrobial agents and chemotherapy 20130601
Title: Summary of ceftaroline fosamil clinical trial studies and clinical safety.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120901
Title: Early response of ceftaroline fosamic in the treatment of soft-tissue infections.
Journal: Expert review of clinical pharmacology 20120901
Title: Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
Journal: Drugs 20120730
Title: Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
Journal: Clinical therapeutics 20120401
Title: New drugs 2012 part I.
Journal: Nursing 20120301
Title: Panton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studies.
Journal: PloS one 20120101
Title: Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20111115
Title: Ceftaroline (Teflaro): a new cephalosporin.
Journal: The Nurse practitioner 20111101
Title: Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
Journal: The Annals of pharmacotherapy 20111101
Title: Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy.
Journal: Expert review of anti-infective therapy 20110801
Title: Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Journal: The Journal of antimicrobial chemotherapy 20110401
Title: Ceftaroline fosamil: a new broad-spectrum cephalosporin.
Journal: The Journal of antimicrobial chemotherapy 20110401
Title: FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
Journal: The Journal of antimicrobial chemotherapy 20110401
Title: FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
Journal: The Journal of antimicrobial chemotherapy 20110401
Title: Review of ceftaroline fosamil microbiology: integrated FOCUS studies.
Journal: The Journal of antimicrobial chemotherapy 20110401
Title: Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia.
Journal: The Journal of antimicrobial chemotherapy 20110401
Title: What are the properties that make an antibiotic acceptable for therapy of community-acquired pneumonia?
Journal: The Journal of antimicrobial chemotherapy 20110401
Title: Changing needs of community-acquired bacterial pneumonia: experience with ceftaroline fosamil. Preface.
Journal: The Journal of antimicrobial chemotherapy 20110401
Title: Ceftaroline fosamil (Teflaro) - a new IV cephalosporin.
Journal: The Medical letter on drugs and therapeutics 20110124
Title: Ceftaroline fosamil: drug profile and clinical data.
Journal: Future microbiology 20110101
Title: New drugs: Ceftaroline fosamil, pegloticase, and eribulin mesylate.
Journal: Journal of the American Pharmacists Association : JAPhA 20110101
Title: [Ceftaroline fosamil, a broad spectrum cephalosporin antibiotic for the treatment of community-acquired pneumonia and complicated skin and skin structure infections].
Journal: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20110101
Title: Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20101215
Title: The problem of complicated skin and skin structure infections: the need for new agents.
Journal: The Journal of antimicrobial chemotherapy 20101101
Title: Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity.
Journal: The Journal of antimicrobial chemotherapy 20101101
Title: CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
Journal: The Journal of antimicrobial chemotherapy 20101101
Title: CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
Journal: The Journal of antimicrobial chemotherapy 20101101
Title: Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
Journal: The Journal of antimicrobial chemotherapy 20101101
Title: Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
Journal: The Journal of antimicrobial chemotherapy 20101101
Title: Evaluation of the in vivo efficacy of intramuscularly administered ceftaroline fosamil, a novel cephalosporin, against a methicillin-resistant Staphylococcus aureus strain in a rabbit endocarditis model.
Journal: The Journal of antimicrobial chemotherapy 20101001
Title: Ceftaroline fosamil: a novel broad-spectrum cephalosporin.
Journal: Drugs of today (Barcelona, Spain : 1998) 20101001
Title: Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens.
Journal: Pharmacotherapy 20100401
Title: Stability and stabilization studies of TAK-599 (Ceftaroline Fosamil), a novel N-phosphono type prodrug of anti-methicillin resistant Staphylococcus aureus cephalosporin T-91825.
Journal: Chemical & pharmaceutical bulletin 20081001
Title: Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection.
Journal: Current opinion in investigational drugs (London, England : 2000) 20080201
Title: Ishikawa T, et, al. TAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties. Bioorg Med Chem. 2003 May 29;11(11):2427-37.
Title: Jacqueline C, et, al. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model. Antimicrob Agents Chemother. 2007 Sep;51(9):3397-400.
Title: Parish D, et, al. Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection. Curr Opin Investig Drugs. 2008 Feb;9(2):201-9.
